SLC12A9-AS1

Across TCGA pan-cancer cohorts, SLC12A9-AS1 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated SLC12A9-AS1 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher SLC12A9-AS1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated SLC12A9-AS1 expression acts as an unfavorable survival marker, although some lineages such as READ and BRCA show a favorable association.

READ, KICH, and BRCA are the cancer types where SLC12A9-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Median	III,IV	0.911	0.396	.001	56	view →
KICH	DFS	Quartile	III,IV	0.177	0.913	.003	40	view →
BRCA	OS	Tertile	All	0.978	0.952	.010	32	view →
PAAD	DFS	Median	All	0.392	0.574	<.001	31	view →
PRAD	DFS	Tertile	All	0.694	0.901	.001	18	view →
SARC	OS	Tertile	All	0.649	0.825	.005	17	view →
DLBC	OS	Median	All	1.000	0.804	.007	13	view →
THYM	DFS	Tertile	All	0.896	0.514	.012	12	view →
LIHC	OS	Tertile	All	0.402	0.670	.020	11	view →
ESCA	DFS	Median	II,III,IV	1.000	0.399	.013	8	view →
PCPG	DFS	Median	All	0.625	0.943	.011	6	view →
BLCA	DFS	Median	IV	0.315	0.140	.027	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

SLC12A9-AS1–READ (OS)

Open the READ breakdown →